Squamous Cell Lung Cancer Clinical Trials

57 clinical trials for Squamous Cell Lung Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of ZEN003694 in People With Squamous Cell Lung Cancer — RECRUITING · PHASE2
• An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer — RECRUITING · PHASE1
• The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma — RECRUITING
• GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression — RECRUITING · PHASE1
• APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch — RECRUITING
• A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
• Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients — COMPLETED
• Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab — SUSPENDED · PHASE1
• Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery — ACTIVE_NOT_RECRUITING · NA
• CISH Inactivated TILs in the Treatment of NSCLC — WITHDRAWN · PHASE1
• Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC — COMPLETED · PHASE1
• Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors — TERMINATED · PHASE1
• Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs — COMPLETED
• Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC. — NOT_YET_RECRUITING · PHASE2
• Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations — COMPLETED · PHASE2
• Icotinib for Completed Resected IB NSCLC With EGFR Mutation — COMPLETED · PHASE2
• A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer — COMPLETED · PHASE3
• Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer — COMPLETED · PHASE1
• FGFR Inhibitor in FGFR Dysregulated Cancer — TERMINATED · PHASE2
• Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island — COMPLETED
• Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor — TERMINATED · PHASE2
• Exhaled Breath Particles in Lung Cancer — OTHER
• Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519) — OTHER
• Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer — COMPLETED · PHASE1
• Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer — COMPLETED · PHASE1
• Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer — WITHDRAWN · PHASE1
• An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC) — OTHER · PHASE2
• Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 — TERMINATED · PHASE2
• A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers — OTHER · PHASE1
• Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China — COMPLETED
• Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease — WITHDRAWN · NA
• Photodynamic Therapy for the Prevention of Lung Cancer — WITHDRAWN · PHASE2
• Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer — COMPLETED · PHASE2
• Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease — COMPLETED
• A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC — OTHER · PHASE2
• Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers — OTHER · PHASE2
• Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens — COMPLETED · PHASE2
• Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care — COMPLETED · NA
• A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer — OTHER · PHASE2
• Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — COMPLETED · PHASE3
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer — OTHER · NA
• Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy — OTHER · PHASE2
• S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer — COMPLETED · PHASE2
• Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC — WITHDRAWN · PHASE1
• Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery — COMPLETED · PHASE3
• Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer — OTHER
• Photodynamic Therapy in Treating Patients With Lung Cancer — COMPLETED · PHASE1
• Dasatinib in Advanced Squamous Cell Lung Cancer — TERMINATED · PHASE2
• Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer — COMPLETED · PHASE3
• Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer — COMPLETED · PHASE2

Refine this search